HOUSTON, Aug. 21, 2014 /PRNewswire-USNewswire/ --
Professional Compounding Centers of America (PCCA) will recognize
innovation in paediatric medicine by awarding the three best
scientific presentations at the sixth European Paediatric
Formulation initiative (EuPFI) conference. The Formulating
Better Medicines for Children conference, held
September 17 – 18 in Athens, Greece, includes dozens of
poster-style scientific presentations by pharmacy students and
professionals, from which three winners will be selected by a panel
of judges.
The conference enables participants to present, discuss
breakthroughs and expand their knowledge about recent developments
and challenges in the area of paediatric medicine and
administration devices, from academia, industry, hospitals, and
regulatory authorities. It will bring together international
leaders in the fields of paediatric formulation development to
discuss emerging topics in these areas. Fabiana Banov, MS,
RPh, formulation development chemist, will represent PCCA on
the panel of judges.
Maria Carvalho, Ph.D., European
compounding expert and PCCA's academic and scientific liaison said,
"PCCA supports innovation in customized medicines. The regulatory
environment for paediatric medicines in the European Union places a
high priority on better protecting children's health. A key part of
PCCA's role is to support the scientific community to develop and
exploit existing, emerging and new technologies to develop better
medicines for children." Winners will each be awarded
€245 each along with the recognition of their
peers.
PCCA is the largest U.S.-based supplier of chemicals, formulas,
equipment and training for compounding pharmacists, who make
customized medicines. The company is widely considered to be the
founder of the modern compounding-pharmacy profession. It has
operations in the U.S., Canada,
Australia and Europe.
The European Paediatric Formulation Initiative (EuPFI) is a
consortium working in a pre-competitive way on paediatric
drug formulations. Members are from academia, hospital
pharmacies, the pharmaceutical industry and contract research
organizations, with the European Medicines Agency as an observer.
The conference in Athens is
presented in partnership with the International Association of
Pharmaceutical Technology.
Carvalho added, "Compounding pharmacists have long been
innovators in developing custom medicines for people with special
needs that cannot be met by the manufactured medicines available.
Compounding also provides an alternative for discontinued drugs and
new drug-associations and strengths. We want to support that type
of work wherever it is being done."
About PCCA
PCCA helps compounding pharmacies around
the world deliver personalized, compounded medications that make a
difference in people's lives. As a compounding pharmacist's most
comprehensive resource, PCCA provides products, services and
support to almost 4,000 pharmacist members throughout the United States, Canada, Australia and the United Kingdom. Serving compounding
pharmacists since 1981, PCCA is headquartered in Houston, Texas. For more information about the
company, visit pccarx.com.
SOURCE PCCA